Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients

Background and objectives: Vascular calcification and endothelial dysfunction contribute to the development of cardiovascular disease in patients with chronic kidney disease (CKD). Sevelamer, a non–calcium-based phosphate binder, has been shown to attenuate cardiovascular calcification in CKD patien...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Caglar, Kayser, Yilmaz, Mahmut Ilker, Saglam, Mutlu, Cakir, Erdinc, Acikel, Cengizhan, Eyileten, Tayfun, Yenicesu, Mujdat, Oguz, Yusuf, Vural, Abdulgaffar, Carrero, Juan Jesus, Axelsson, Jonas, Lindholm, Bengt, Stenvinkel, Peter
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2008
Teme:
Clinical Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2390988/
https://ncbi.nlm.nih.gov/pubmed/18057307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.02810707
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items